Why women’s bodies respond differently to exercise — and how to train accordingly

Women’s hormonal cycles affect strength, endurance, and recovery in measurable ways. Here is what the evidence on cycle-synced training actually supports — and where it runs out.

Oestrogen and progesterone do things to muscle, ligaments, core temperature, and fuel use. That part is not in dispute. What is in dispute — and what the apps selling four-phase workout plans tend to skip — is whether those measurable physiological shifts translate into performance differences large enough to plan a training week around. The honest answer, from the researchers who have actually pooled the data, is that they mostly do not.

What genuinely changes across a cycle

The physiology is real. In the follicular phase, oestrogen rises toward an ovulatory peak; in the luteal phase, progesterone dominates. Several downstream effects are well documented.

Also read

Supplement Reviews

Ancient + Brave True Collagen review: the cleanest label in the category, the loosest claims

28 Aug 2026

Supplement Reviews

Nutravita Omega 3 review: the same numbers as its rivals, and the only label that explains them

28 Aug 2026

Core body temperature rises in the luteal phase by a few tenths of a degree, which matters for endurance work in heat because it narrows the margin before heat strain sets in. Substrate use shifts modestly, with oestrogen promoting fat oxidation and some glycogen sparing. Oestrogen also affects collagen metabolism and ligament laxity, which is the basis for research into whether ACL injury risk varies across the cycle. And plasma volume and fluid balance shift enough to move scale weight and perceived effort.

None of that is controversial. The question is what follows from it.

What the performance data actually shows

The most cited synthesis is a 2020 systematic review and meta-analysis in Sports Medicine by McNulty and colleagues, pooling studies of exercise performance across cycle phases in naturally menstruating women. Its conclusion was deliberately modest: performance may be trivially reduced during the early follicular phase compared with other phases, the effect size was small enough to be practically negligible for most people, and the overall quality of the underlying evidence was low. The authors’ own recommendation was individualised, symptom-led adjustment rather than a general phase-based prescription.

For resistance training specifically, a 2023 review by Colenso-Semple and colleagues went further, concluding that current evidence shows no influence of cycle phase on acute strength performance or on adaptations to resistance training. That is a direct challenge to the most popular version of cycle syncing — the one that assigns heavy lifting to the follicular phase and light movement to the luteal phase.

Why the studies are as weak as they are

This is worth understanding, because “the evidence is low quality” gets read as “the evidence is against it” when it more often means nobody has tested it properly yet.

The core methodological problem is verification. A large share of published studies assigned participants to a cycle phase by counting days from the last period, without measuring hormone concentrations or confirming that ovulation occurred. Cycles vary in length between women and between months in the same woman, ovulation does not always happen, and hormone concentrations at a given day vary enormously. A study that mislabels its phases cannot detect a phase effect even if one exists.

Sample sizes compound it. Most studies enrolled small groups and tested performance at a single time point per phase, which is a poor design for detecting small effects against high individual variability. Methodological guidance published in 2021 by Elliott-Sale and colleagues set out what a properly controlled study in this area requires — hormone verification, adequate sampling, clear phase definitions — and relatively little of the existing literature meets it. Research is now being done to that standard, which is why this is a topic where the picture may genuinely change.

Where the effect is real: symptoms, heat, and contraception

The strongest signal in this area is not hormonal — it is symptomatic. Large surveys of active women consistently find that a substantial majority report their cycle affecting training, most often around menstruation itself, and most often through cramps, fatigue, headaches, and disrupted sleep rather than through any measurable drop in force production. Those symptoms are a legitimate reason to modify a session. They are also highly individual, which is precisely why a population-level phase template is the wrong tool.

Heat is the clearest genuine application. Given the luteal-phase temperature rise, prolonged endurance work in hot conditions is one context where planning around the cycle has a defensible physiological rationale rather than a speculative one.

Hormonal contraception complicates everything above. Combined oral contraceptives suppress the natural cycle and replace it with a different hormonal pattern, so cycle-syncing advice built on natural fluctuation does not transfer. A 2020 meta-analysis found only trivial performance differences between users and non-users, again on low-quality evidence.

What to do instead

The approach the researchers themselves recommend is not “ignore your cycle” — it is to track your own rather than adopt someone else’s template. Log training sessions alongside cycle day and how you actually felt: energy, perceived effort, sleep, symptoms. After three or four cycles, patterns either appear or they do not, and either result is useful information about your body specifically rather than about women on average.

Where a consistent pattern does appear, adjust around it — scheduling the heaviest or most technical session away from the days you reliably feel worst is sensible planning, not pseudoscience. Where no pattern appears, which is a common outcome, the absence is not a failure to track properly. It is a finding.

The practical takeaway

Cycle syncing has been marketed several steps ahead of its evidence. The physiology it points at is genuine, the performance effects measured so far are small and inconsistently detected, and the specific four-phase programmes sold to women have never been tested against the alternative of training consistently and adjusting when symptoms warrant it. That alternative remains the better-supported default. If a phase-based plan makes training feel more considered and you stick with it, there is little harm in it — but do not skip sessions on the theory that your hormones have made them pointless, and treat any programme claiming precise phase-specific prescriptions as making claims the research does not currently support.